Novaccess Global

Chesterland, United States

Novaccess Global brings together technological assets, scientific, and executive team to accelerate taking these assets to market.

$10.7M raised

Jan 2024

Post-IPO Equity

Biopharma Biotechnology Medical

Top Investors

Sumner Global

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Novaccess Global

How much funding has Novaccess Global raised?

Novaccess Global has raised $10.7M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2024.

Who are Novaccess Global's investors?

Novaccess Global's investors include Sumner Global.

Where is Novaccess Global headquartered?

Novaccess Global is headquartered in Chesterland, United States.

What does Novaccess Global do?

Novaccess Global brings together technological assets, scientific, and executive team to accelerate taking these assets to market.

What stage is Novaccess Global at?

Novaccess Global is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 2, 2024.

MLA

"Novaccess Global — Funding & Investors." VCBacked, January 2, 2024, https://www.vcbacked.co/company/novaccess-global. Accessed July 3, 2026.

APA

VCBacked. (2024). Novaccess Global — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/novaccess-global

Wikipedia (cite web)

{{cite web |title=Novaccess Global — Funding & Investors |url=https://www.vcbacked.co/company/novaccess-global |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 2, 2024.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.